THE MECHANISM OF ALLOXAN PROTECTION IN EXPERIMENTAL ATHEROSCLEROSIS by Cook, D. L. et al.
THE  MECHANISM  OF  ALLOXAN PROTECTION  IN 
EXPERIMENTAL  ATHEROSCLEROSIS 
BY D. L. COOK, P~r.D., LOIS M. MILLS, AND D. M. GREEN,* M.D. 
(From the Division of Biological Research, G. D. Searle and Co., Chicago) 
(Received for publication, September 4, 1953) 
A  decreased  severity  of  atherosclerosis  in  cholesterol-fed alloxan-diabetic 
rabbits,  despite  marked  lipemia  and  hypercholesterolemia, was  reported by 
Duff and McMillan (1) and Duff and Payne (2). These results were confirmed 
by  Pierce  (3)  who  found  a  negative  correlation between  serum  cholesterol 
levels  and  the  degree  of  atherosclerosis  in  such  animals.  Simultaneous 
measurements of ultracentrifugal patterns  of serum showed high concentra- 
tions of molecules above S/100, indicating a metabolic block in the conversion 
of lipoproteins to lower S! classes in the alloxan-diabetic rabbit. 
The relative freedom of diabetic cholesterol-fed rabbits from atherosclerosis 
was  considered  to  be  associated  with  the  diabetic  state,  and  Duff  and 
McMillan  (1)  tentatively  concluded  that  "alloxan-recovered" animals  pro- 
vided a suitable control for the effects of alloxan per se. 
Although  alloxan alters the cytology of the anterior pituitary and adrenal glands 
(4) and of the kidney and liver (5), it is generally agreed that its diabetogenic action 
is due to a rapid and selective action on the pancreatic islets of Langerhans.  Leech 
and Bailey (6) first reported that alloxan,  after addition to blood in vilro or intra- 
venous injection into rabbits, disappears  from the blood  completely in  5 minutes 
or less. These results were confirmed by Karrer a  al.  (7). Gomori and Goldner  (8) 
occluded portions of the pancreas from the circulation  and found that the diabeto- 
genic potency of alloxan is rapidly lost after injection. 
The present  studies  were designed  to  determine  whether  alloxan-injected 
rabbits in which diabetogenic action of alloxan is prevented, retain resistance 
to  atherosclerosis.  The  procedure  involved  a  comparison  of  the  effects  of 
cholesterol  feeding  in  normal  rabbits,  in  rabbits  previously  made  diabetic 
with alloxan,  and  in rabbits in  which alloxan had  been administered during 
temporary occlusion of the pancreatic circulation. 
Methods and Materials 
Three groups of male rabbits, obtained from Ora Robinson Bunny Ranch, Osceola, Il- 
linois, were the  experimental animals. Fifteen rabbits  received intravenous injections of 
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150 rag.  per kg. of aUoxan monohydrate  (Eastman Kodak Co.), followed immediately by a 
subcutaneous dose of 10 cc. of 20 per cent glucose solution. The glucose was repeated in the 
same dose 3 additional times at 2 hour intervals to counteract the acute and transient hypo- 
glycemia which follows the administration of alloxan. Five surviving rabbits showed blood 
glucose leveh greater than 400 nag. per cent and were considered to be in a  diabetic state. 
This group was designated as the alloxan-diabetic group. 
The second group consisted of rabbits which survived following administration of alloxan 
during temporary exclusion of the pancreas from the circulation. These aulmah were anes- 
thetized with 30 rag.  per kg. of sodium pentobarbital given intravenously. Ether was used 
as a  supplementary anesthetic when necessary. The abdominal wall was opened aseptically 
and the peritoneal cavity exposed.  The celiac artery and other arterial branches supplying 
the pancreas were clamped, and  150 mg. per kg. of aUaxan were injected intravenously into 
a  marginal ear vein. After an interval of 5 minutes the damps were removed and the ind- 
sion dosed.  Glucose was administered  in a  manner identical to that  described for the al- 
loxan-diabetic group.  Seven out of 21  rabbits  survived this procedure and showed normal 
blood glucose levels. These seven rabbits were considered to be non-diabetic and are referred 
to as the pancreas-protected group. 
The third  group  consisted of ten control rabbits  which received no treatment prior to 
cholesterol feeding. 
Several weeks were allowed to lapse after the alloxan injections so that the transient Hpe- 
mia and hypercholesterolemia foUowing a11oxan would subside before the rabbits were put 
on the cholesterol diet. Control samples were then obtained from all rabbits.  Each animal 
was housed in an individual cage and given water and food ad libi~m. The diet consisted 
of Rockland rabbit ration modified by the addition of cholesterol in a  1 per cent concentra- 
tion. Each animal was weighed weekly and its food consumption recorded twice per week. 
Serum lipoproteins and total cholesterol concentrations were determined at monthly inter- 
vals during the experiment. Blood glucese levels were measured on heparinized blood sam- 
ples at 2 week intervah. 
Lipoprotein  analyses  were  made  according  to  the  ultracentrifugal  flotation  method  of 
Gofman e~ d.  (9) modified by subdivision of the S! 10-15  and S! 16-30 classes  (10).  Blood 
glucose was determined by the procedure described by Bums  (11).  Serum total cholesterol 
was determined by the Foldes and Wilson (12) modification of the Schoenheimer and Sperry 
(13) method. 
All animals were sacrificed  at the end of 56 days of the high cholesterol  diet.  The degree 
of atherosclerosis  was graded into 5 classes  (0-4)  according to the area of aortic  intima in- 
volved by the lesions.  The lipoprotein  and total  cholesterol  concentrations were averaged 
for each rabbit over the period of cholesterol  feeding and the group means calculated.  The 
degree of atherosclerosis  was compared with these mean values, since the formation of le- 
sions  is  presumably dependent upon the concentrations of lipoprotelns  throughout the entire 
period of exposure, rather than at any given time. 
The statistical significances  of differences  between group means were tested by Student's 
t test (14). 
RESULTS 
The  individual  data  are  presented  in  Table  I,  while  the  group  means  are 
summarized in Fig.  I. 
The ages sad initial weights of the rabbits used for each group were similar. 
The  initial  levels  of  serum  cholesterol  and  lipoprotein  did  not  differ  sig- 
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TABLE  1 
Lend of LipoproSdns  and Cholesterol in Three Groups of Rabbits Fed Cholesterol 
Each value represents the mean of two determinations performed at 4 and 8 weeks during the 
8 week period of cholesterol  feeding.  The degree of atherosclerosis  found at the end of the 8th week 
is also included. 
Lipoprotein  concentration 
Weight  Food  Glucme;  per 100 cc. serum  Total  Deog~ee 
con-  per 100  I  cholesterol  Rabbit  Age  s'emp- 
Group  No.  Ratio of  tion  cc.  per 100 cc.  athero- 
Initial  final to  blood  serum  sclerosis 
initial  per day i 
d~ys  kg. 
~,lloxan-  1  193  3.60  1.07 
diabetic  2  133  2.79  1.08 
3  153  2.29  1.00 
4  137  2.84  1.13 
3  136  3.09  1.17 
Kean .4- s.o.* .......  154 4- 23  2.92  1.09 
-4-0.48  ~0.07 
?ancreas-  6  162  2.91  1.13 
protected  7  180  2.99  1.17 
8  148  3.03  1.18 
9  144  3.31  1.29 
10  134  3.23  1.14 
11  134  2.42  1.29 
12  134  2.79  1.19 
Micah 4- s.D.*  .......  148 4- 17  2.95  1.20 
-4-0.29  d~0.07 
C,  ontrois  13  131 
14  148 
15  131 
16  131 
17  126 
18  126 
19  126 
20  126 
21  126 
22  131 
! 
M[ean.t-  s.D.* .......  1304-6  J 
I 
I 
S  I 5-9 [SJ 10-13 S  t 16-3( 
I 
gm./k&,  mg.  mg.  mg.  mg.  mg, 
43  665  295  260  860  1493  2 
33  437  273  238  1631  2140  2-3 
80  600  395  230  1300  2882  0 
79  527  600  190  1400  5112  4 
59  496  265  140  1100  3234  4 
63.4-  16  M5 4- 89  366  212  1258  2972  ::t:: 1373 2.5 -,'- 1.~ 
::1::141  ,4-47  .4-293 
39  122  165  180  805  1449  3 
37  122  235  255  920  1403  2-3 
33  131  124  82  295  811  4 
43  131  235  255  880  1363  4 
34  132  87  135  525  1210  4 
35  123  84  125  405  1309  3 
34  115  207  292  788  2096  3 
! 36.4- 3  125.4- 6  168  189  660  1378  -t- 381  3.4 4- 0.~ 
4-73  "4-79  -4-249 
3.45  1.14  35  129  155  200  1100  1484  1-2 
3.08  1.12  32  134  119  275  320  1236  4 
3.21  1.17  34  129  370  330  1250  2878  3 
3.49  1.12  34  123  235  340  855  1651  4 
3.05  1.16  36  134  355  430  1300  2423  4 
3.24  1.08  30  128  250  280  990  1561  2 
3.02  1.20  34  127  215  170  575  1390  1 
3.08  1.08  35  134  109  168  56,$  1438  2 
3.54  1.11  38  131  130  215  470  1395  3--4 
3.20  1.19  33  124  130  275  630  1822  4 
3.24  1.14[34:i:21129-4-4t  207  268  j  828  11728-t-522  2.9-t-1.3 
-4-0.19  -4-0.42 I  ,4-95  .4-82  ::t::313 
• Standard deviation "  ,-I~-- 1~, in which Z(z ) represents the summation of the squares of the individuat de- 
viations from the mosa and ~  the number of determinations. 
The weight gain  during  the experiment, as  indicated  by the ratio of the 
final  to  initial  weight,  was  slightly  less  for  the  alloxan-diabetic group  and 
slightly greater for the pancreas-protected group than for the controls. These 
differences were not statistically significant--a result of potential importance 
since  it  has  been  shown  that  weight  loss  can  inhibit  the  development of 
atherosclerosis (15). CHOLESTEROL 
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FIo.  1. Summary of the mean cholesterol consumption, serum cholesterol, and  lipoprotein 
levels and degree of atheroselerosis for three groups of rabbits. Large S  between bars  indi- 
rotes that the difference between the two  corresponding means is signiticant at P  <  0.05. 
An X  between bars ~di~tes no significant difference. 
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The alloxan-diabetic  animals showed  a  highly significant  increase  (about 
double)  in  cholesterol  and  food  consumption  over  the  pancreas-protected 
and the control groups. No significant difference in consumption was demon- 
strated between the latter two groups. The serum cholesterol and lipoprotein 
(Sz 5-9  and SI  16-30) levels of the alloxan-diabetic  animals were also  sig- 
nificantly higher  than  those  of  the  controls.  No  significant  differences  in 
serum cholesterol or lipoprotein  levels were observed  between  the pancreas- 
protected and control groups. 
The degree of atherosclerosis did not differ significantly  among any of the 
groups.  It averaged 2.5  for the alloxan-diabetic  animals and 3.4 and 2.9 for 
the pancreas-protected  and control groups respectively. 
DISCUSSION 
These observations  suggest  that the exaggerated  hypercholesterolemia  and 
lipoproteinemia  of the alloxan-diabetic  animals  resulted  from a  greatly in- 
creased dietary intake, consequent  upon the diabetic state. 
Results previously reported (10) showed that the degree of atherosclerosis 
produced in normal rabbits by cholesterol  feeding was directly and linearly 
related to the cholesterol intake and to the serum cholesterol and lipoprotein 
concentrations.  The failure of the alloxan-diabetic  group to develop a greater 
degree  of  atherosclerosis  than  the  controls,  despite  provocatively  higher 
cholesterol  intake,  hypercholesterolemia,  and  lipoproteinemia,  suggests  that 
the  atherogenic  mechanism  was  retarded  in  this  group,  although  not  in- 
hibited. 
The failure of alloxan to lessen the degree of atherosclerosis relative to the 
untreated controls  when its diabetogenic  effect was prevented, indicates  that 
its protective action is associated  with the particular diabetic state produced 
by its action on the pancreas, and not by an action on extra-pancreatic  tissues. 
SWM~A~Y 
Experiments were performed  to compare  the effects of cholesterol feeding 
in  (a)  control  rabbits,  (b)  alloxan-diabetic  rabbits,  and  (c)  rabbits  injected 
with alloxan  while the pancreas  was  temporarily occluded from the circula- 
tion. 
The  alloxan-diabetic  rabbits  consumed  significantly  higher  quantities  of 
cholesterol and food and had serum cholesterol and lipoprotein  (SI 5-9 and Sf 
16-30)  concentrations significantly  increased  over  the  control  levels. They 
failed to show a commensurate  increase in the degree of atherosclerosis. 
Rabbits  in  which  the  diabetogenic  action  of  alloxan  was  prevented  by 
temporary occlusion of the pancreas  from the circulation  during its adminis- 
tration developed  grades  of hypercholesterolemia,  hyperlipoproteinemia,  and 
atherosclerosis not significantly different from the controls. 124  ALLOXAN DIABETES AND ATHEROSCLEROSI$ 
The  results are interpreted as indicating that the effects of aUoxan  on 
tissues other than the pancreas do not protect against experimental athero- 
sclerosis  produced bv cholesterol  feeding. 
Acknowledgm~mt is made to Dr. Roger  Ray, Department of Chemistry,  Universitv  of 
Illinois, for the ultrscentrifugal analyses reported in this study. 
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